Mostrando 6 resultados de: 6
Filtros aplicados
Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use
ArticleAbstract: There is growing consensus on the potential use of pharmacogenetics in clinical practice, and hopesPalabras claves:Autores:Adrián LLerena, Cáceres M.C., Dorado P., Licinio J., Pozo-Guisado E., Wong M.L.Fuentes:scopusCYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
ArticleAbstract: Earlier we had found that the CYP2C9*2 allelic frequency was lower in Mexican-Americans living in CaPalabras claves:CYP2C9, Hispanics, Mexican-Americans, Mexican-Mestizos, Mexican-Tepehuanos, pharmacogeneticsAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Licinio J., Penãs-Lledó E.M., Sosa-Macías M.G., Wong M.L.Fuentes:scopusEditorial
OtherAbstract:Palabras claves:Autores:Administrador Revistas UTE, Adrián LLerena, Aguilar Gordón F.D.R., Alejandro Speck-Planche, Alfred Kron̈er, Alvaro Santiago Solano Gallegos, Ayestarán S., Benson A., Darío R. Páez, Darwin Ordoñez Iturralde, Davey K., David Ricardo Achig Balarezo, Davila A., Eduardo V. Ludeña, Elisa Bonaccorso, Eugenia Wickens, Eve Cerón Pérez, Floralba del Rocío Aguilar-Gordón, Freddy Portilla Farfán, Gisela Raymond Cornejo, Gustavo Moreno-Martín, Henry Pazmiño A, Hoorn C., Iankova K., Jaime Padilla Verdugo, Jaime Patricio Abad Vázquez, Javier González Díez, Jefferson Moreno Guaicha, Jimena Peñaherrera Wilches, José Luis Crespo-Fajardo, Juan Manuel Guayasamin, Klerkx J., Licinio J., Linder H., Marcos De Donato, María Sol Villagómes, Marian Wiercigroch, Matilde J. Flores Urbáez, Mauricio Ortega-Andrade, Miriam Gallegos, Naranjo-Gil D., Nelson José Labarca Ferrer, Nicola Pontarollo, Nikola Petrovic, Orville-Thomas W.J., Palavitsinis N., Pedro Jimenez-Pacheco, Pedro Longart, Rafael Iturralde Solórzano, Richard J. Aspinall, Schandelmeier H., Smeyers Y.G., Stern R.J., Tilbury J., Viazzo P.P., Xavier Ochoa, Yachana , Yachana Revista Científica, Yntze van der Hoek, Zulbey Rivero de RodríguezFuentes:googlerraaescopusInfluence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico
ArticleAbstract: We previously documented the lowest frequency of CYP2C9*2 in Mexican indigenous Tepehuanos followedPalabras claves:ancestral components, CYP2C9, Mexican indigenous, pharmacogeneticsAutores:Adrián LLerena, Dorado P., Galaviz-Hernandez C., Lazalde-Ramos B.P., Licinio J., Martínez-Fierro M.L., Martínez-Sevilla V.M., Rangel-Villalobos H., Salazar-Flores J., Sosa-Macías M.G., Wong M.L.Fuentes:scopusLower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards
ArticleAbstract: Interethnic differences in cytochrome P450 polymorphism might be responsible, at least in part, forPalabras claves:CYP2C9, Hispanics, Mexican-Americans, pharmacogenetics, SpaniardsAutores:Adrián LLerena, Dorado P., Jepson R., Licinio J., O'Kirwan F., Wong M.L.Fuentes:scopusPharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education
ArticleAbstract: Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decadePalabras claves:Adverse drug reactions (ADRs), Continuing medical education, Cytochrome P450 enzymes, Education, International Society of Pharmacogenetics (ISP), personalized medicine, pharmacogenetics, Thiopurine methyltransferase (TPMT)Autores:Adrián LLerena, Dedoussis G., Flordellis C.S., Fuhr U., Gurwitz D., Kirchheiner J., Licinio J., Lunshof J.E., Manolopoulos V.G., Sheffield L.J., Siest G., Torricelli F., Vasiliou V., Wong S.Fuentes:scopus